Objective: To test for replication of the association between variants in the CLU, CR1, and PICALM genes with Alzheimer disease. Design: Follow-up case-control association study. Setting: The Mayo Clinics at Jacksonville, Florida, and Rochester, Minnesota. Participants: Community-based patients of European descent with late-onset Alzheimer disease (LOAD) and controls without dementia who were seen at the Mayo clinics, and autopsy-confirmed cases and controls whose pathology was evaluated at the Mayo Clinic in Jacksonville. Additional samples were obtained from the National Cell Repository for Alzheimer Disease (NCRAD).Atotal of 1829 LOAD cases and 2576 controls were analyzed. Interventions: The most significant single-nucleotide polymorphisms in CLU (rs11136000), CR1 (rs3818361), and PICALM (rs3851179) were tested for allelic association with LOAD. Main Outcome Measure: Clinical or pathology-confirmed diagnosis of LOAD. Results: Odds ratios forCLU, CR1, and PICALM were 0.82, 1.15, and 0.80, respectively, comparable in direction and magnitude with those originally reported. P values were 8.6 × 10-5, .014, and 1.3 × 10-5, respectively; they remain significant even after Bonferroni correction for the 3 single-nucleotide polymorphisms tested. Conclusion: These results show near-perfect replication and provide the first additional evidence that CLU, CR1, and PICALM are associated with the risk of LOAD.
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Clinical Neurology